B.C. Women's Hospital & Health Centre, an agency of the Provincial Health Services Authority, is a Canadian hospital located in Vancouver, British Columbia, Canada, specializing in women's health programs.

During the past decade, BC Women's Hospital conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 27 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BC Women's Hospital" #1 sponsor was "University of British Columbia" with 56 trials, followed by "Children's Oncology Group" with 34 trials sponsored, "BC Women's Hospital & Health Centre" with 6 trials sponsored, "The Hospital for Sick Children" with 6 trials sponsored and "CHU de Quebec-Universite Laval" with 6 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BC Women's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 14 trials as a collaborator, "Sunnybrook Health Sciences Centre" with 5 trials as a collaborator, "Genome British Columbia" with 4 trials as a collaborator and "Genome Canada" with 4 trials as a collaborator. Other collaborators include 130 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "BC Women's Hospital" are "Leukemia" (9 trials), "Sarcoma" (9 trials), "Neuroblastoma" (8 trials), "Pregnancy" (7 trials) and "Brain Tumor" (6 trials). Many other conditions were trialed in "BC Women's Hospital" in a lesser frequency.

Most popular intervention types in "BC Women's Hospital" are "Drug" (70 trials), "Procedure" (32 trials), "Biological" (22 trials), "Other" (18 trials) and "Device" (15 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (19 trials), "cyclophosphamide" (17 trials), "filgrastim" (14 trials), "vincristine sulfate" (14 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "BC Women's Hospital" are 85 trials for "All" genders, 53 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 28 active trials in "BC Women's Hospital". 1 are not yet recruiting, 13 are recruiting, 11 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 95 completed trials in BC Women's Hospital, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in BC Women's Hospital, 11 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 36 trials that are defined as “Not Applicable".